Gland Pharma News

Motilal Oswal has recently released its December 2022 Results Preview report, where the brokerage has picked Ajanta Pharma, Apollo Hospitals, Dr Reddy's Labs, Eris Lifesciences, Gland Pharma, Granules, Ipca Laboratories, Laurus Labs, Piramal Pharma, Solara Active Pharma Sciences, and Sun Pharmaceutical ...

Brokerage firm Sharekhan has assigned buy call to mid-cap stock, Can Fin Homes and hold call to small cap stock, Gland Pharma. The brokerage firm has downgraded Gland Pharma to hold with a target price of Rs 1689 apiece. The brokerage ...

Motilal Oswal, in its latest report, has suggested investors to invest in 5 stocks promising good returns. These stocks are Angel One, Eris Lifesciences, Gland Pharma, Laurus Labs, and Brigade Enterprise. If you buy these stocks today, you can ger maximum ...

Motilal Oswal has recommended investors to buy small cap Pharmaceuticals sector stock, Gland Pharma Ltd with a target price of Rs 2660 apiece. The current market price of Gland Pharma is Rs 1693 apiece. The company has a market capitalisation of Rs 27,892.45 crore. Check key takeaways below:{photo-feature} ...

Gland Pharma Ltd came into existence in 1978 and over the years grown from a contract manufacturer of small volume liquid parenteral products to emerge one of the biggest and fastest growing generic injectables manufacturing companies. It has a global ...

On Wednesday, Indian shares were barely moving as investors prepared for a significant rate hike from the U.S. Federal Reserve and signs of further increases. The S&P BSE Sensex was down 100 points at 59,600 levels while the Nifty50 was trading ...

Acknowledged brokerage firm Motilal Oswal suggests buying the stocks of Gland Pharma, for good returns in the short term. Mentioning the expected up-gradation of the stock, the brokerage firm stated, "Based on its launch momentum, filing pace, the upside from recently ...